Journal articles on the topic 'Compound heterozygotes'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Compound heterozygotes.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Girolami, Antonio, Elisabetta Cosi, Silvia Ferrari, Bruno Girolami, and Maria L. Randi. "Thrombotic Events in Homozygotes with a Proven or Highly Probable Arg304Gln Factor VII Mutation (FVII Padua)1): Only Limited Replacement Therapy is Needed in Case of Surgery." Cardiovascular & Hematological Disorders-Drug Targets 19, no. 3 (2019): 233–38. http://dx.doi.org/10.2174/1871529x19666190308114842.
Full textNg, Kevin, Erron W. Titus, Krystien V. Lieve, et al. "An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia." Circulation 142, no. 10 (2020): 932–47. http://dx.doi.org/10.1161/circulationaha.120.045723.
Full textHo, PJ, J. Rochette, CA Fisher, et al. "Moderate reduction of beta-globin gene transcript by a novel mutation in the 5' untranslated region: a study of its interaction with other genotypes in two families." Blood 87, no. 3 (1996): 1170–78. http://dx.doi.org/10.1182/blood.v87.3.1170.bloodjournal8731170.
Full textRossi, Enrico, Max K. Bulsara, John K. Olynyk, Digby J. Cullen, Lesa Summerville, and Lawrie W. Powell. "Effect of Hemochromatosis Genotype and Lifestyle Factors on Iron and Red Cell Indices in a Community Population." Clinical Chemistry 47, no. 2 (2001): 202–8. http://dx.doi.org/10.1093/clinchem/47.2.202.
Full textYazdanyar, Shiva, Maren Weischer, and Børge G. Nordestgaard. "Genotyping for NOD2 Genetic Variants and Crohn Disease: a Metaanalysis." Clinical Chemistry 55, no. 11 (2009): 1950–57. http://dx.doi.org/10.1373/clinchem.2009.127126.
Full textRossi, Enrico, John K. Olynyk, Digby J. Cullen, et al. "Compound Heterozygous Hemochromatosis Genotype Predicts Increased Iron and Erythrocyte Indices in Women." Clinical Chemistry 46, no. 2 (2000): 162–66. http://dx.doi.org/10.1093/clinchem/46.2.162.
Full textAlcalay, R. N., A. Siderowf, R. Ottman, et al. "Olfaction in Parkin heterozygotes and compound heterozygotes: The CORE-PD study." Neurology 76, no. 4 (2010): 319–26. http://dx.doi.org/10.1212/wnl.0b013e31820882aa.
Full textFelice, Alexander, Joseph Borg, Wilma Cassar, et al. "Hb F Malta I in Association with Hb F Sardinia (AyT) and Hb Valletta in Heterozygotes: Quantification of the Six Globins Suggests Developmental Control of the XMN-I Site and Interplay with the (AT)xTy Sequence in Connection with Globin Gene Switching." Blood 108, no. 11 (2006): 3830. http://dx.doi.org/10.1182/blood.v108.11.3830.3830.
Full textSuh, Ji Hyung, Ik Hee Ryu, Jin Pyo Hong, et al. "Phenotypes of Granular Corneal Dystrophy Type 2 among Koreans in Their Twenties." Journal of the Korean Ophthalmological Society 63, no. 12 (2022): 965–72. http://dx.doi.org/10.3341/jkos.2022.63.12.965.
Full textDi Taranto, Maria Donata, Carola Giacobbe, Alessio Buonaiuto, et al. "A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia." Journal of Clinical Medicine 9, no. 1 (2020): 219. http://dx.doi.org/10.3390/jcm9010219.
Full textSecondes, Eriza S., Daniel F. Wallace, Gautam Rishi, et al. "Increased Allele Frequency of GNPAT p.D519G in Compound HFE p.C282Y/p.H63D Heterozygotes with Elevated Serum Ferritin Levels." Blood 134, Supplement_1 (2019): 4807. http://dx.doi.org/10.1182/blood-2019-128240.
Full textSchöniger-Hekele, M., F. Wrba, E. Penner, Ch Müller, and P. Ferenci. "Hepatic pathology in C282Y/H63D compound heterozygotes." Journal of Hepatology 32 (2000): 133. http://dx.doi.org/10.1016/s0168-8278(00)80840-5.
Full textTorpy, David J., Anthony W. Bachmann, Jeffrey E. Grice, et al. "Familial Corticosteroid-Binding Globulin Deficiency Due to a Novel Null Mutation: Association with Fatigue and Relative Hypotension." Journal of Clinical Endocrinology & Metabolism 86, no. 8 (2001): 3692–700. http://dx.doi.org/10.1210/jcem.86.8.7724.
Full textBeránek, Martin, M. Drastíková, J. Bureš, and V. Palička. "Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants." Folia Biologica 61, no. 3 (2015): 91–96. http://dx.doi.org/10.14712/fb2015061030091.
Full textBacanu, Silviu-Alin. "Testing for Modes of Inheritance Involving Compound Heterozygotes." Genetic Epidemiology 37, no. 5 (2013): 522–28. http://dx.doi.org/10.1002/gepi.21732.
Full textSatyagraha, Ari Winasti, Arkasha Sadhewa, Lydia Visita Panggalo, et al. "Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria." PLOS Neglected Tropical Diseases 15, no. 7 (2021): e0009610. http://dx.doi.org/10.1371/journal.pntd.0009610.
Full textSchuster, Volker, Silvia Seidenspinner, Petra Zeitler, et al. "Compound-Heterozygous Mutations in the Plasminogen Gene Predispose to the Development of Ligneous Conjunctivitis." Blood 93, no. 10 (1999): 3457–66. http://dx.doi.org/10.1182/blood.v93.10.3457.410k03_3457_3466.
Full textAlpert, Norman R., Saidi A. Mohiddin, Dorothy Tripodi, et al. "Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations." American Journal of Physiology-Heart and Circulatory Physiology 288, no. 3 (2005): H1097—H1102. http://dx.doi.org/10.1152/ajpheart.00650.2004.
Full textChaubal, Gaurav, Amith Kumar Pakkala, Aditya J. Nanavati, et al. "Compound Heterozygous Familial Hypercholesterolemia in a Child: Successfully Treated by Liver Transplant from Heterozygous Living Donor." Indian Pediatrics Case Reports 3, no. 4 (2023): 220–24. http://dx.doi.org/10.4103/ipcares.ipcares_29_23.
Full textSt-Arnaud, René, Martin Pellicelli, Mahmoud Ismail, Alice Arabian, Toghrul Jafarov, and Chengji J. Zhou. "NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH." International Journal of Molecular Sciences 23, no. 2 (2022): 940. http://dx.doi.org/10.3390/ijms23020940.
Full textLevy, Michal, Lily Bazak, Noa Lev-El, et al. "Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome." Genes 14, no. 10 (2023): 1854. http://dx.doi.org/10.3390/genes14101854.
Full textBorg, Kristian, Rolf Stucka, Matthew Locke, et al. "Intragenic deletion ofTRIM32in compound heterozygotes with sarcotubular myopathy/LGMD2H." Human Mutation 30, no. 9 (2009): E831—E844. http://dx.doi.org/10.1002/humu.21063.
Full textAlloisio, N., P. Texier, A. Vallier, et al. "Modulation of Clinical Expression and Band 3 Deficiency in Hereditary Spherocytosis." Blood 90, no. 1 (1997): 414–20. http://dx.doi.org/10.1182/blood.v90.1.414.
Full textAlloisio, N., P. Texier, A. Vallier, et al. "Modulation of Clinical Expression and Band 3 Deficiency in Hereditary Spherocytosis." Blood 90, no. 1 (1997): 414–20. http://dx.doi.org/10.1182/blood.v90.1.414.414_414_420.
Full textHusein, Wanes, Marten, Zimmer, and Naim. "Heterozygotes Are a Potential New Entity among Homozygotes and Compound Heterozygotes in Congenital Sucrase-Isomaltase Deficiency." Nutrients 11, no. 10 (2019): 2290. http://dx.doi.org/10.3390/nu11102290.
Full textKenny, Dermot, Ólafur G. Jónsson, Patricia A. Morateck та Robert R. Montgomery. "Naturally Occurring Mutations in Glycoprotein Ibα That Result in Defective Ligand Binding and Synthesis of a Truncated Protein". Blood 92, № 1 (1998): 175–83. http://dx.doi.org/10.1182/blood.v92.1.175.413a36_175_183.
Full textKoziol, James A., Ngoc J. Ho, Vincent J. Felitti, and Ernest Beutler. "Reference Centiles for Serum Ferritin and Percentage of Transferrin Saturation, with Application to Mutations of the HFE Gene." Clinical Chemistry 47, no. 10 (2001): 1804–10. http://dx.doi.org/10.1093/clinchem/47.10.1804.
Full textAnastasovska, V., and M. Kocova. "Intron 2 Splice Mutation at CYP21 Gene in Patients with Congenital Adrenal Hyperplasia in the Republic of Macedonia." Balkan Journal of Medical Genetics 13, no. 2 (2010): 27–33. http://dx.doi.org/10.2478/v10034-010-0023-7.
Full textWest, John D., Graham Fisher, John F. Loutit, Michael J. Marshall, Norman W. Nisbet, and V. Hugh Perry. "A new allele of microphthalmia induced in the mouse: microphthalmia - defective iris (midi)." Genetical Research 46, no. 3 (1985): 309–24. http://dx.doi.org/10.1017/s0016672300022801.
Full textPoullis, A., SJ Moodie, L. Ang, CJ Finlayson, GE Levin, and JD Maxwell. "Routine transferrin saturation measurement in liver clinic patients increases detection of hereditary haemochromatosis." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 40, no. 5 (2003): 521–27. http://dx.doi.org/10.1258/000456303322326434.
Full textPuro, Jaakko. "Meiotic behaviour of compound chromosomes in tricomplex heterozygotes in Drosophila melanogaster." Genetical Research 46, no. 3 (1985): 287–307. http://dx.doi.org/10.1017/s0016672300022795.
Full textSriphrapradang, Chutintorn, Yardena Tenenbaum-Rakover, Mia Weiss, et al. "The Coexistence of a Novel Inactivating Mutant Thyrotropin Receptor Allele with Two Thyroid Peroxidase Mutations: A Genotype-Phenotype Correlation." Journal of Clinical Endocrinology & Metabolism 96, no. 6 (2011): E1001—E1006. http://dx.doi.org/10.1210/jc.2011-0127.
Full textNarzi, L., A. Stamato, R. Cresta, et al. "The variable phenotype of (TGJ^Ts or L997F compound heterozygotes." Journal of Cystic Fibrosis 7 (June 2008): S5. http://dx.doi.org/10.1016/s1569-1993(08)60022-3.
Full textCoss�e, Mireille, Alexandra D�rr, Mich�le Schmitt, et al. "Friedreich's ataxia: Point mutations and clinical presentation of compound heterozygotes." Annals of Neurology 45, no. 2 (1999): 200–206. http://dx.doi.org/10.1002/1531-8249(199902)45:2<200::aid-ana10>3.0.co;2-u.
Full textGoel, Neha, Kanika Kapoor, Srilatha Bajaj, and Sumita Saluja. "Compound heterozygous delta beta thalassemia with IVS 1-5 (G>C) mutation presenting as thalassemia major phenotype." International Journal of Contemporary Pediatrics 8, no. 12 (2021): 1993. http://dx.doi.org/10.18203/2349-3291.ijcp20214543.
Full textJohnson, F., Janina Longtine, Nils Kucher, Hylton Joffe, Ruliang Xu, and Samuel Goldhaber. "Warfarin dosing and cytochrome P450 2C9 polymorphisms." Thrombosis and Haemostasis 91, no. 06 (2004): 1123–28. http://dx.doi.org/10.1160/th04-02-0083.
Full textValiyeva, S. I., S. Kh Kurbanova, I. R. Gaziyev, and D. Yu Ovsyannikov. "Genotypic and phenotypic characteristics of pediatric patients with familial Mediterranean fever (a periodic disease) in one of the Russia regions." Pediatria. Journal named after G.N. Speransky 103, no. 6 (2024): 17–25. https://doi.org/10.24110/0031-403x-2024-103-6-17-25.
Full textByrd, DennIs J., Marion Lind, and Johannes Brodehl. "Diagnostic and genetic studies in 43 patients with classic cystinuria." Clinical Chemistry 37, no. 1 (1991): 68–73. http://dx.doi.org/10.1093/clinchem/37.1.68.
Full textGabriková, Dana, Iveta Boroňová, Ivan Bernasovský, et al. "Hemochromatosis gene mutations in the general population of Slovakia." Open Medicine 6, no. 2 (2011): 148–51. http://dx.doi.org/10.2478/s11536-010-0067-9.
Full textSmetanina, N. S., L.-H. Gu, L. Simjanovska та ін. "α-, β-, and y-mRNA Levels in β-Thalassemia; Transcriptional and Translational Differences in Heterozygotes, Homozygotes, and Compound Heterozygotes". Hemoglobin 21, № 1 (1997): 27–39. http://dx.doi.org/10.3109/03630269708997508.
Full textFurukawa, Yoshiaki, James J. Filiano, and Stephen J. Kish. "Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes forGCH1 mutations." Movement Disorders 19, no. 10 (2004): 1256–58. http://dx.doi.org/10.1002/mds.20194.
Full textMoens, C. B., B. R. Stanton, L. F. Parada, and J. Rossant. "Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus." Development 119, no. 2 (1993): 485–99. http://dx.doi.org/10.1242/dev.119.2.485.
Full textIchinose, Aya, Hideaki Moteki, Mitsuru Hattori, Shin-ya Nishio, and Shin-ichi Usami. "Novel Mutations in LRTOMT Associated With Moderate Progressive Hearing Loss in Autosomal Recessive Inheritance." Annals of Otology, Rhinology & Laryngology 124, no. 1_suppl (2015): 142S—147S. http://dx.doi.org/10.1177/0003489415575043.
Full textAhmed, Abubaker Y., John McLaughlin, Scott E. Levison, Catherine Fullwood, and Alistair Makin. "Su1450 – Chronic Pancreatitis Associated with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutations – a Comparison of Heterozygotes and Compound Heterozygotes." Gastroenterology 156, no. 6 (2019): S—555. http://dx.doi.org/10.1016/s0016-5085(19)38278-2.
Full textBozzini, Claudia, Natascia Campostrini, Paola Trombini, et al. "Measurement of Urinary Hepcidin Levels by SELDI-TOF-MS in HFE-Hemochromatosis." Blood 110, no. 11 (2007): 2668. http://dx.doi.org/10.1182/blood.v110.11.2668.2668.
Full textLethagen, Stefan, Christina Isaksson, Charlotta Schaedel, and Lars Holmberg. "Von Willebrand’s Disease caused by Compound Heterozygosity for a Substitution Mutation (T1156M) in the D3 Domain of the Von Willebrand Factor and a Stop Mutation (Q2470X)." Thrombosis and Haemostasis 88, no. 09 (2002): 421–26. http://dx.doi.org/10.1055/s-0037-1613232.
Full textVan Dorland, Anette Anette, Magnus Mansouri Taleghani, Kenneth Dale Friedman, et al. "Genotype-Phenotype Correlation in Congenital TTP: New Insights from a Multicentre Study with 121 Patients." Blood 132, Supplement 1 (2018): 376. http://dx.doi.org/10.1182/blood-2018-99-112095.
Full textPerez Botero, Juliana, Rajiv K. Pruthi, William L. Nichols, Aneel A. Ashrani, and Mrinal M. Patnaik. "von Willebrand disease type1/type 2N compound heterozygotes: diagnostic and management challenges." British Journal of Haematology 176, no. 6 (2016): 994–97. http://dx.doi.org/10.1111/bjh.14028.
Full textBergmann, Anke K., Inderneel Sahai, Jill F. Falcone, et al. "Thiamine-Responsive Megaloblastic Anemia: Identification of Novel Compound Heterozygotes and Mutation Update." Journal of Pediatrics 155, no. 6 (2009): 888–92. http://dx.doi.org/10.1016/j.jpeds.2009.06.017.
Full textGurrin, Lyle C., Nadine A. Bertalli, Gregory W. Dalton, et al. "HFEC282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity." Hepatology 50, no. 1 (2009): 94–101. http://dx.doi.org/10.1002/hep.22972.
Full text